These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23512680)

  • 1. Formulating weakly basic HCl salts: relative ability of common excipients to induce disproportionation and the unique deleterious effects of magnesium stearate.
    John CT; Xu W; Lupton LK; Harmon PA
    Pharm Res; 2013 Jun; 30(6):1628-41. PubMed ID: 23512680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of excipient properties, water activity, and water content on the disproportionation of a pharmaceutical salt.
    Patel MA; Luthra S; Shamblin SL; Arora KK; Krzyzaniak JF; Taylor LS
    Int J Pharm; 2018 Jul; 546(1-2):226-234. PubMed ID: 29772284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Metallic Stearates on Disproportionation of Hydrochloride Salts of Weak Bases in Solid-State Formulations.
    Nie H; Xu W; Ren J; Taylor LS; Marsac PJ; John CT; Byrn SR
    Mol Pharm; 2016 Oct; 13(10):3541-3552. PubMed ID: 27542728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Microenvironmental Acidity: A Strategy to Mitigate Salt Disproportionation in Drug Product Environment.
    Koranne S; Lalge R; Suryanarayanan R
    Mol Pharm; 2020 Apr; 17(4):1324-1334. PubMed ID: 32142293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Excipients on Salt Disproportionation during Dissolution: A Novel Application of In Situ Raman Imaging.
    Abouselo A; Rance GA; Tres F; Taylor LS; Kwokal A; Renou L; Scurr DJ; Burley JC; Aylott JW
    Mol Pharm; 2021 Sep; 18(9):3247-3259. PubMed ID: 34399050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disproportionation of Pharmaceutical Salts: pH
    Avdeef A
    Mol Pharm; 2021 Jul; 18(7):2724-2743. PubMed ID: 34142831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the Influence of Excipients on the Stability of Levothyroxine Sodium Pentahydrate.
    Kaur N; Suryanarayanan R
    Mol Pharm; 2021 Jul; 18(7):2683-2693. PubMed ID: 34061524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of Spatial Heterogeneity of Salt Disproportionation in Tablets by Synchrotron X-ray Diffractometry.
    Koranne S; Govindarajan R; Suryanarayanan R
    Mol Pharm; 2017 Apr; 14(4):1133-1144. PubMed ID: 28195490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of In-Situ-Generated Moisture on Disproportionation of Pharmaceutical Salt.
    Weldeab AO; McElderry JD; Lin Y
    Mol Pharm; 2023 Jan; 20(1):561-571. PubMed ID: 36524757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salt Disproportionation in the Solid State: Role of Solubility and Counterion Volatility.
    Thakral NK; Behme RJ; Aburub A; Peterson JA; Woods TA; Diseroad BA; Suryanarayanan R; Stephenson GA
    Mol Pharm; 2016 Dec; 13(12):4141-4151. PubMed ID: 27766882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying Disproportionation in Pharmaceutical Formulations with
    Hirsh DA; Su Y; Nie H; Xu W; Stueber D; Variankaval N; Schurko RW
    Mol Pharm; 2018 Sep; 15(9):4038-4048. PubMed ID: 30016112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing quality by design in pharmaceutical salt selection: a modeling approach to understanding disproportionation.
    Merritt JM; Viswanath SK; Stephenson GA
    Pharm Res; 2013 Jan; 30(1):203-17. PubMed ID: 22918819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of drug-excipient interaction in the formulation of celecoxib tablets.
    Bozdağ-Pehlivan S; Subaşi B; Vural I; Unlü N; Capan Y
    Acta Pol Pharm; 2011; 68(3):423-33. PubMed ID: 21648198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pharmaceutical excipients on the stability of angiotensin-converting enzyme inhibitors in their solid dosage formulations.
    Stanisz B; Regulska K; Kania J; Garbacki P
    Drug Dev Ind Pharm; 2013 Jan; 39(1):51-61. PubMed ID: 22348774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disproportionation of the calcium salt of atorvastatin in the presence of acidic excipients.
    Christensen NP; Rantanen J; Cornett C; Taylor LS
    Eur J Pharm Biopharm; 2012 Oct; 82(2):410-6. PubMed ID: 22824098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of salt and excipient properties on disproportionation in the solid-state.
    Guerrieri P; Taylor LS
    Pharm Res; 2009 Aug; 26(8):2015-26. PubMed ID: 19507008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Miniaturized approach for excipient selection during the development of oral solid dosage form.
    Raijada D; Müllertz A; Cornett C; Munk T; Sonnergaard J; Rantanen J
    J Pharm Sci; 2014 Mar; 103(3):900-8. PubMed ID: 24436033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of compacted hydrophobic and hydrophilic colloidal silicon dioxide on tableting properties of pharmaceutical excipients.
    Jonat S; Hasenzahl S; Gray A; Schmidt PC
    Drug Dev Ind Pharm; 2005 Aug; 31(7):687-96. PubMed ID: 16207616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative Salt Selection and Formulation Optimization: Perspectives of Disproportionation and Microenvironmental pH Modulation.
    Mohan S; Li Y; Chu K; De La Paz L; Sperger D; Shi B; Foti C; Rucker V; Lai C
    Mol Pharm; 2024 May; 21(5):2590-2605. PubMed ID: 38656981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-excipient interactions resulting from powder mixing. IV: Role of lubricants and their effect on in vitro dissolution.
    Chowhan ZT; Chi LH
    J Pharm Sci; 1986 Jun; 75(6):542-5. PubMed ID: 3735097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.